HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

rhodamine-phalloidin

a fluorescent dye that binds polymerized actin

Networked: 28 relevant articles (0 outcomes, 4 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Huang, Chih-Yang: 3 articles (07/2021 - 05/2008)
2.	Kuo, Wei-Wen: 3 articles (07/2021 - 05/2008)
3.	Shibu, Marthandam Asokan: 2 articles (07/2021 - 11/2018)
4.	Kuo, Chia-Hua: 2 articles (11/2018 - 05/2008)
5.	Alwjwaj, Mansour: 1 article (10/2021)
6.	Bayraktutan, Ulvi: 1 article (10/2021)
7.	Kadir, Rais Reskiawan A: 1 article (10/2021)
8.	McCarthy, Zoe: 1 article (10/2021)
9.	Barik, Parthasarathi: 1 article (07/2021)
10.	Chang, Yung-Ming: 1 article (07/2021)

Related Diseases

1.	Cardiomegaly (Heart Hypertrophy) 11/01/2018 - "Interestingly, we could observe that supplementation of EJLE could rescue Ang-II induced cardiac hypertrophy as evident through Western blot, rhodamine phalloidin staining, and Hematoxylin-Eosin staining. " 01/01/2023 - "Cardiac hypertrophy was evaluated using heart weight/body weight (HW/BW), RT-PCR, hematoxylin-eosin (HE), and rhodamine phalloidin staining. " 05/01/2008 - "In our study of H9c2 cardiomyoblast cell cultures, we used the rhodamine phalloidin staining to measure the cell hypertrophy and western blot to measure the expression of cardiac hypertrophy markers atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in cells treated with IGF-II. We found that a significant association between IGF2R overexpression and myocardial infarction. "
2.	Hypertrophy 07/01/2021 - "Further, we cocultured the H9c2 cells with rADSCs and the results revealed that Danggui-treated MSCs enhanced the IGF1R expression and attenuated the hypertrophy in H9c2 cells against Ang II challenge by immunoblot and rhodamine-phalloidin staining. " 05/01/2008 - "In our study of H9c2 cardiomyoblast cell cultures, we used the rhodamine phalloidin staining to measure the cell hypertrophy and western blot to measure the expression of cardiac hypertrophy markers atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in cells treated with IGF-II. We found that a significant association between IGF2R overexpression and myocardial infarction. "
3.	Carcinoma (Carcinomatosis) 11/22/1996 - "Western blot analysis of intracellular actin in cells exposed to cucurbitacins and quantitation of rhodamine-phalloidin binding support the hypothesis that cucurbitacin treatment leads to an inappropriate increase in the filamentous or polymerized actin fraction in prostate carcinoma cells. " 05/27/1994 - "Competitive binding studies using rhodamine-phalloidin suggest that jasplakinolide binds to F-actin competitively with phalloidin with a dissociation constant of approximately 15 nM. This compares favorably to the previously reported IC50 of 35 nM for the antiproliferative effect of jasplakinolide on PC3 prostate carcinoma cells. "
4.	Myocardial Infarction 05/01/2008 - "In our study of H9c2 cardiomyoblast cell cultures, we used the rhodamine phalloidin staining to measure the cell hypertrophy and western blot to measure the expression of cardiac hypertrophy markers atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in cells treated with IGF-II. We found that a significant association between IGF2R overexpression and myocardial infarction. "
5.	Ischemia 10/01/1992 - "In this study, using rhodamine-phalloidin which stains only filamentous actin, we demonstrate that graded durations of ischemia resulted in progressive disruption of proximal tubule apical microfilaments. "

Related Drugs and Biologics

1.	Actins (F Actin)
2.	Brain Natriuretic Peptide (Natrecor)
3.	Phalloidine
4.	Atrial Natriuretic Factor (ANF)
5.	Insulin-Like Growth Factor II (Somatomedin A)
6.	jasplakinolide
7.	Hematoxylin (Haematoxylon)
8.	Eosine Yellowish-(YS) (Eosin)
9.	Cucurbitacins
10.	Keratin-14 (Keratin 14)

Related Therapies and Procedures

1.	Lasers (Laser)